Russia approves 2nd coronavirus vaccine after early trials October 14, 2020 Get link Facebook X Pinterest Email Other Apps The peptide-based, two-shot vaccine, EpiVacCorona, was developed by the Vector Institute in Siberia from The Hindu - Home https://ift.tt/3nTdJJe https://ift.tt/2IyLjhI Comments
Comments
Post a Comment